Segments - Electromagnetic Surgical Navigation System Market by Application (Neurosurgery, ENT Surgery, Cardiac Surgery, Orthopedic Surgery, and Others), End-user (Hospitals, Ambulatory Surgical Centers, and Others), and Region (Asia Pacific, North America, Latin America, Europe, and Middle East & Africa) - Global Industry Analysis, Growth, Share, Size, Trends, and Forecast 2023 – 2031
The global electromagnetic surgical navigation system market size was USD 543.12 Billion in 2022 and is likely to reach USD 1075.79 Billion by 2031, expanding at a CAGR of 7.89% during 2023–2031. The market growth is attributed to growing prevalence of minimally invasive surgery.
Growing prevalence of minimally-invasive surgery is expected to boost the demand for the electromagnetic surgical navigation system. This system helps surgeons perform minimally invasive surgeries with high accuracy and precision, encouraging hospitals and doctors to adopt electromagnetic surgical navigation systems for non-invasive surgery.
Electromagnetic surgical navigation systems allow surgeons to precisely track instrument positions. The tracked position of the instrument is projected onto the preoperative imaging data, to allow surgeons to perform minimally invasive surgeries. It consists of a robot, a computer, an optical tracking system (OTS), and dynamic reference frames (DRF). Electromagnetic surgical navigation systems are used in neurosurgery, ENT surgery, cardiac surgery, orthopedic surgery, and other surgeries.
The COVID-19 pandemic hampered the demand for electromagnetic surgical navigation systems. The abrupt rise in COVID-19 infection encouraged governments to impose social distancing and lockdowns, which sharply declined the demand for clinic visits and elective surgeries. This impeded the market as electromagnetic surgical navigation systems are used in surgical procedures to assist surgeons in precise and accurate guidance by integrating real-time imaging technology, computer algorithms, and tracking devices. For instance,
According to the National Library of Medicine, a 54% reduction was seen in total surgeries in 2020, due to the postponement of elective surgical procedures.
The implementation of artificial intelligence in electromagnetic surgical navigation systems is an immense opportunity in the market. AI in electromagnetic surgical navigation systems assists in the development of advanced navigation and guidance systems, which help improve the precision of the surgical procedure accuracy. AI-powered surgical navigation systems identify and track surgical instruments, providing real-time guidance to the surgeon during the procedure.
Increasing prevalence of brain tumors and ENT disorders is expected to boost the demand for electromagnetic surgical navigation systems. Electromagnetic surgical navigation systems are utilized in the surgery of brain tumors, as they help surgeons safely find the way around the brain and precisely locate tumors. Thus, rising prevalence of brain tumors is propelling the market.
Rising incidences of chronic diseases such as cancer and neurological disorders is projected to drive the market. Chronic diseases require regular monitoring to check the progress or regress of the disease and the development of complications. Electromagnetic surgical navigation systems provide precise diagnosis, planning, and execution of surgical procedures, leading to improved patient outcomes, which encourages its adoption for chronic disease management. Therefore, growing incidences of chronic diseases is expected to propel the market. For instance,
According to a report published by the World Health Organization on September 16, 2023, 41 million people are killed every year globally due to chronic diseases, which is equivalent to 74% of all deaths globally.
High costs associated with electromagnetic surgical navigation systems encourages small- and mid-size hospitals and clinics lessens their adoption. Moreover, the presence of metal or ferromagnetic sources in the operating workspace affects the efficiency and measurement accuracy of electromagnetic surgical navigation systems, which is projected to hamper the market.
Rising healthcare expenditure in emerging nations is anticipated to create a lucrative opportunity in the market. Moreover, increasing investments in R&D activities by major players in the market to develop and introduce new electromagnetic surgical navigation systems with added features and technology creates an immense opportunity in the market. For instance,
On May 02, 2023, Koninklijke Philips N.V. a Dutch-based multinational company that develops and manufactures medical systems, launched Zenition 10. It helps expand patient access to routine surgical care and minimally invasive procedures and enables surgeons to treat more patients at a low cost, while improving patient outcomes.
The report on the market includes an assessment of the market, trends, segments, and regional markets. Overview and dynamics have also been included in the report.
Attributes |
Details |
Report Title |
Electromagnetic Surgical Navigation System Market - Global Industry Analysis, Growth, Share, Size, Trends, and Forecast |
Base Year |
2022 |
Historic Data |
2016–2021 |
Forecast Period |
2023–2031 |
Segmentation |
Application (Neurosurgery, ENT Surgery, Cardiac Surgery, Orthopedic Surgery, and Others) and End-user (Hospitals, Ambulatory Surgical Centers, and Others) |
Regional Scope |
Asia Pacific, North America, Latin America, Europe, and Middle East & Africa. |
Report Coverage |
Company Share, Market Analysis and Size, Competitive Landscape, Growth Factors, and Trends, and Revenue Forecast |
Key Players Covered in the Report |
B. Braun SE; Brainlab AG; Brain Navi Biotechnology Co., Ltd; Corin; Johnson & Johnson Services, Inc.; Karl Storz SE & Co. KG; Medtronic; Northern Digital Inc; Smith+Nephew; Siemens Healthcare GmbH; Stryker; and Zimmer Biomet |
Based on application, the electromagnetic surgical navigation system market is categorized as neurosurgery, ENT surgery, cardiac surgery, orthopedic surgery, and others. The neurosurgery segment held a large share of the market in 2022 due to an increasing number of patients seeking treatment for conditions such as brain tumors, stroke, and traumatic brain injuries.
Neurosurgery requires precise diagnosis and accurate procedures, which can be fulfilled by an electromagnetic surgical navigation system, as it allows accurate localization of vital anatomic structures, such as cranial nerves or carotid arteries. Moreover, it provides a real-time display of a tracked instrument, which enhances the confidence and efficiency of surgeons. This increases the demand for electromagnetic surgical navigation systems in neurosurgery.
The ENT surgery segment is projected to grow at a rapid pace in the coming years owing to the growing prevalence of sinusitis and rising incidences of ENT disorders. An electromagnetic surgical navigation system is required in ENT surgery, as it helps surgeons perform minimally invasive surgery by providing alignment validation to surgeons during surgical procedures and improved intraoperative feedback.
In terms of end-users, the global market is segregated into hospitals, ambulatory surgical centers, and others. The hospitals segment accounted for a major share of the market in 2022 due to the increasing demand for wellness and greater access to medical facilities.
Electromagnetic surgical navigation systems are extensively used in hospitals to improve point-of-care (PoC) and enable fast and accurate results. Hospitals offer a large array of treatment options for orthopedic procedures and pain management, which enhances the demand for electromagnetic surgical navigation systems in hospitals.
The ambulatory surgical centers segment is anticipated to grow at a quick pace in the coming years owing to rising demand for minimally invasive treatments and shortage of hospital beds. Electromagnetic surgical navigation systems are used in ambulatory surgical centers to provide a faster recovery rate and are easy and precise to perform surgeries than traditional therapies and treatments.
Based on region, the electromagnetic surgical navigation system market is divided into Asia Pacific, North America, Latin America, Europe, and Middle East & Africa. North America dominated the market in 2022 due to rising prevalence of orthopedic, ENT, and neurological disorders, and the presence of key market players such as Johnson & Johnson Services, Inc., Stryker, and Zimmer Biomet. Moreover, increasing incidence of chronic diseases in the region is propelling the demand for electromagnetic surgical navigation system, as it is used to treat chronic diseases by enabling precise diagnosis, planning, and execution of surgical procedures, leading to improved patient outcomes. For instance,
According to a report published by the National Library of Medicine, approximately 45% or 133 million people in the US suffer from at least one chronic disease, and the number is expected to grow in the coming years.
The market in Asia Pacific is projected to expand at a high CAGR during the assessment year owing to growing medical tourism and increasing population. Moreover, rising geriatric population in the region is estimated to boost the demand for electromagnetic surgical navigation systems, as the geriatric population needs minimally invasive surgeries. Additionally, rising healthcare spending by the government is propelling the market. For instance,
The government of India introduced the Union Budget of India on February 1, 2023, stating the allocation of ₹89,155 crores for the Ministry of Health.
The electromagnetic surgical navigation system market has been segmented on the basis of
Key players competing in the global market are B. Braun SE; Brainlab AG; Brain Navi Biotechnology Co., Ltd; Corin; Johnson & Johnson Services, Inc.; Karl Storz SE & Co. KG; Medtronic; Northern Digital Inc; Smith+Nephew; Siemens Healthcare GmbH; Stryker; and Zimmer Biomet.
These companies adopted development strategies including collaboration, product launches, mergers, acquisitions, partnerships, and production expansion to expand their consumer base worldwide. For instance,
On 23 November 2021, Brain Navi Biotechnology Co., Ltd a Taiwan-based leading surgical robotic company received CE mark approval for brain surgery procedures for its NaoTrac, a robotic-assisted surgical robot. NaoTrac is equipped with a high-precision navigation system that helps surgeons with precise anatomical locations during the pre-operating planning preparation.